Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

Healthcare Diagnostics & Research
"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Response Biomed Corp
Bullboard Posts
User Avatar Image
(2)
•••
Comment by dimar66on Mar 14, 2010 6:37pm
382 Views
Post# 16881636

RE: My View

RE: My ViewI have no idea of what your insights are but I would say that if we are talking about which quater we should see something significant that is an improvement of how we used to say which year.  Now that both 3M and Roche have introduced their products the next stage we would be entering is the steepest part of the curve regarding increasing sales.  Shouldn't Roche be introducing cardiac Ramp into the Canadian market now?  Just wondering.

dimar
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities